Document:

Exhibit 4.1

AMENDMENT NO. 2
TO
382 RIGHTS AGREEMENT

This Amendment No. 2 to 382 Rights Agreement (this “Amendment”) is entered into as of August 7, 2018, by and between Windstream Holdings, Inc., a Delaware corporation (the “Company”), and Computershare Trust Company, N.A., a federally chartered trust company (the “Rights Agent”).

WHEREAS, the Company and the Rights Agent previously entered into that certain 382 Rights Agreement, dated as of September 17, 2015, as amended by Amendment No. 1 to 382 Rights Agreement, dated as of November 5, 2016 (collectively, the “Rights Agreement”);

WHEREAS, the Board of Directors of the Company has determined in good faith that the amendments to the Rights Agreement set forth herein are desirable, has duly authorized and adopted such amendment(s) to the Rights Agreement, and, pursuant to Section 27 of the Rights Agreement, has directed that such amendment(s) to the Rights Agreement be made;

WHEREAS, at the 2018 annual meeting of stockholders of the Company, the Company’s stockholders authorized a three-year extension of the term of the Rights Agreement, which, but for the amendments to the Rights Agreement set forth herein, would expire on September 17, 2018 in accordance with the terms of the Rights Agreement;

WHEREAS, the Company has delivered to the Rights Agent a certificate executed by an appropriate officer of the Company stating that this Amendment is in compliance with the terms of Section 27 of the Rights Agreement; and

WHEREAS, for the purposes of this Amendment, capitalized terms not otherwise defined herein shall have the respective meanings set forth in the Rights Agreement, as amended by this Amendment.

NOW, THEREFORE, in consideration of the premises and the mutual agreements herein set forth, the parties hereto hereby agree as follows:

1. Amendments.

(a) The Rights Agreement is hereby amended by deleting and replacing Section 1(s) thereof in its entirety as follows:

“(s) “Final Expiration Date” shall mean the date upon which the Rights expire and shall be the earlier of 5:00 P.M., New York City time on September 17, 2021, unless the Rights are previously redeemed, exchanged or terminated.”

(b) Each of the Form of Rights Certificate and the Form of Summary of Rights to Purchase Stock Under 382 Rights Agreement attached to the Rights Agreement as Exhibits B and C, respectively, are hereby amended such that each reference to “September 17, 2018” shall be replaced with a reference to “September 17, 2021”.

2. Severability. If any term, provision, covenant or restriction of this Amendment is held by a court of competent jurisdiction or other authority to be invalid, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions of this Amendment shall remain in full force and effect and shall in no way be affected, impaired or invalidated.

3. Descriptive Headings. Descriptive headings of the several Sections of this Amendment are inserted for convenience only and shall not control or affect the meaning or construction of any of the provisions hereof.

4. Governing Law. This Amendment shall be deemed to be a contract made under the laws of the State of Delaware and for all purposes shall be governed by and construed in accordance with the laws of such State applicable to contracts to be made and to be performed entirely within such State, without regard to conflict-of-law principles.

5. References. Any reference to the Rights Agreement after the date first set forth above shall be deemed to be a reference to the Rights Agreement, as amended by this Amendment.

6. Counterparts. This Amendment may be executed in any number of counterparts and each of such counterparts shall for all purposes be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument. A signature to this Amendment executed and/or transmitted electronically shall have the same authority, effect, and enforceability as an original signature.

[Signature page follows]

IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed, all as of the day and year first above written.

	WINDSTREAM HOLDINGS, INC.
	 
	By: /s/ Kristi Moody
	Name:    	Kristi Moody
	Title:	Senior Vice President – General Counsel and Corporate Secretary
	 
	 
	COMPUTERSHARE TRUST COMPANY, N.A., as Rights Agent
	 
	 
	By: /s/ David L. Adamson
	Name:	David L. Adamson
	Title:	Senior Vice PresidentEX-10.1

 Exhibit 10.1 

SOLID BIOSCIENCES INC. 

NON-EMPLOYEE DIRECTOR COMPENSATION POLICY 

Effective as of July 25, 2018, the non-employee directors of Solid Biosciences Inc. (the
“Company”) shall receive the following compensation for their service as members of the Board of Directors of the Company (the “Board”). Unless otherwise noted, Andrey Zarur, the Chairman of the Board, is not deemed a non-employee director for purposes of this Policy, and his compensation is separately set forth below. 
 Director
Compensation 
 Our goal is to provide compensation for our non-employee directors in a manner
that enables us to attract and retain outstanding director candidates and reflects the substantial time commitment necessary to oversee the Company’s affairs. We also seek to align the interests of our directors and our stockholders and we have
chosen to do so by compensating our non-employee directors with a mix of cash and equity-based compensation. 

Cash Compensation 

The fees that will be paid to our non-employee directors for service on the Board, and for service on
each committee of the Board on which the director is then a member, and the fees that will be paid to the chairperson of each committee of the Board will be as follows: 
  

									
	 	  	Member
Annual
Fee	 	  	Chairperson
Incremental
Annual Fee	 
	 Board of Directors
	  	$	35,000	 	  	 	–  	 
	 Audit Committee
	  	$	7,500	 	  	$	7,500	 
	 Compensation Committee
	  	$	5,000	 	  	$	5,000	 
	 Nominating and Corporate Governance Committee
	  	$	4,000	 	  	$	4,000	 

 The foregoing fees will be payable in arrears in equal semi-annual installments not later than the 15th
business day following the end of the second and fourth calendar quarters, provided that the amount of such payment will be prorated for any portion of such semi-annual period that the director is not serving on the Board, on such committee or in
such position, and no fee shall be payable in respect of any period prior to the completion of our initial public offering. 
 In his role
as Chairman of the Board, Andrey Zarur will be paid cash compensation for fiscal year 2018 in the amount of $225,000. Unless otherwise noted, Dr. Zarur will not receive any other cash or equity compensation described in this Policy. 

 Equity Compensation 

Initial Grants. Upon initial election to our Board, each non-employee director will be granted,
automatically and without the need for any further action by the Board, an initial equity award of an option, with a Black-Scholes value of $100,000, to purchase shares of our common stock. The initial award shall have a term of ten years from the
date of the award, and shall vest and become exercisable as to 1/3 of the shares underlying such award on each anniversary of the grant date until the third anniversary of the grant date, subject to the director’s continued service as a
director through each applicable vesting date. The vesting shall accelerate as to 100% of the shares upon a change in control of the Company. The exercise price shall be the closing price of our common stock on the date of grant. 

Annual Grants. Each non-employee director who has served as a member of our Board for at least
six months prior to the date of our annual meeting of stockholders for a particular year will be granted, automatically and without the need for any further action by the Board, an equity award on the date of our annual meeting of stockholders for
such year of an option, with a Black-Scholes value of $50,000, to purchase shares of our common stock. The annual award shall have a term of ten years from the date of the award, and shall vest and become exercisable in full on the earlier to occur
of the one-year anniversary of the grant date and immediately prior to our first annual meeting of stockholders occurring after the grant date, subject, in each case, to the director’s continued service
as a director through the applicable vesting date. The vesting shall accelerate as to 100% of the shares upon a change in control of the Company. The exercise price shall be the closing price of our common stock on the date of grant. 

The foregoing share amounts shall be automatically adjusted in the event of any change in the capital structure or business of the Company by
reason of any stock split, reverse stock split, stock dividend, combination or reclassification of shares, recapitalization, merger, consolidation, spin off, split off, reorganization or partial or complete liquidation, issuance of rights or
warrants to purchase common stock or securities convertible into common stock, sale or transfer of all or part of the Company’s assets or business, or other corporate transaction or event that would be considered an “equity
restructuring” within the meaning of FASB ASC Topic 718, in each case, pursuant to the terms of our 2018 Omnibus Incentive Plan, or any successor plan. 

The initial awards and the annual awards shall be subject to the terms and conditions of our 2018 Omnibus Incentive Plan, or any successor
plan, and the terms of the option agreements entered into with each director in connection with such awards. 
 Expenses 

Upon presentation of documentation of such expenses reasonably satisfactory to the Company, each
non-employee director (including, in this case, Dr. Zarur) shall be reimbursed for his or her reasonable out-of-pocket
business expenses incurred in connection with the performance of their duties as directors, including travel expenses in connection with their attendance in-person at Board and committee meetings. 

  
 2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00286-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00286-of-00352.parquet"}]]